Altimmune, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Altimmune, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Altimmune, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 71.1M shares, a 34.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 71.1M +18.3M +34.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 71M +18.4M +34.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 70.9M +21.6M +43.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 70.7M +21.5M +43.7% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 52.9M +3.7M +7.52% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 52.7M +6.29M +13.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 49.3M +6.07M +14% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 49.2M +8.21M +20% Dec 31, 2022 10-K 2024-03-27
Q3 2022 49.2M +9.46M +23.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 46.4M +6.68M +16.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 43.2M +4.96M +13% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 41M +3.85M +10.4% Dec 31, 2021 10-K 2023-02-28
Q3 2021 39.7M +6.63M +20% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 39.7M +13.1M +49.5% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 38.3M +22.9M +149% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 37.1M +21.8M +143% Dec 31, 2020 10-K 2022-03-15
Q3 2020 33.1M +17.7M +116% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 26.6M +13.1M +97.4% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 15.4M +1.91M +14.2% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 15.3M +6.23M +68.7% Dec 31, 2019 10-K 2021-02-25
Q3 2019 15.3M +13.6M +789% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 13.5M -23.9M -64% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 13.5M -8.8M -39.5% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 9.08M +8.47M +1392% Dec 31, 2018 10-K 2020-03-27
Q3 2018 1.73M -13.9M -89% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 37.4M +21.9M +142% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 22.3M -46.6M -67.7% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 608K -6.31M -91.2% Dec 31, 2017 10-K 2019-04-01
Q3 2017 15.6M -50.8M -76.5% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 15.4M -49.4M -76.2% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 68.8M +4.37M +6.78% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 6.92M -57.5M -89.3% Dec 31, 2016 10-K 2018-04-02
Q3 2016 66.4M +2.06M +3.21% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 64.8M +874K +1.37% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 64.4M +770K +1.21% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 64.4M +779K +1.22% Dec 31, 2015 10-K 2017-03-14
Q3 2015 64.4M +2.14M +3.44% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 63.9M +8.39M +15.1% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 63.7M +9.9M +18.4% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 63.6M +11.3M +21.6% Dec 31, 2014 10-K 2016-03-11
Q3 2014 62.2M +9.92M +19% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 55.5M +4.35M +8.5% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 53.8M +5.36M +11.1% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 52.3M +3.95M +8.17% Dec 31, 2013 10-K 2015-03-11
Q3 2013 52.3M +3.95M +8.17% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 51.2M +2.83M +5.85% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 48.4M +102K +0.21% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 48.4M +116K +0.24% Dec 31, 2012 10-K 2014-03-11
Q3 2012 48.3M +152K +0.32% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 48.3M +152K +0.32% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 48.3M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 48.2M +2M +4.32% Dec 31, 2011 10-K 2013-03-14
Q3 2011 48.2M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 48.2M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 46.2M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.